Industries / Health / Medical devices / Medical sterilization
Capacity
Capacity is how much sterilizing the world can do, where the plants are, who owns them, and what happens to the supply of devices when one closes.
6
Milestones achieved, from 1959 to 2019.
2
To watch for: announced, not yet confirmed outside.
2
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
1959
A plant for hire
The world's first commercial gamma irradiation plant opened at Dandenong, Victoria, Australia, in 1959 for Gamma Sterilisation Pty Ltd. It held 150,000 curies of cobalt-60 (a curie is a unit of radioactivity) and was built to kill anthrax in goat hair imported for carpets. When synthetic fibres ended that trade, it sterilized medical products and tissues for other companies until 1976. In France, Pierre Vidal's Conservatome opened in 1960 the first irradiator that a private company built to serve outside customers, and by 1970 there were two dozen large gamma plants sterilizing medical devices, most of them in Europe.
LessonContract sterilization began as spare capacity looking for customers; the plant built for one product survived by serving many.
Credit
Gamma Sterilisation Pty Ltd; Pierre Vidal and Conservatome
1974
India's first plant
ISOMED, a cobalt-60 irradiator at the Bhabha Atomic Research Centre in Mumbai, began sterilizing medical devices in 1974. It was set up with the United Nations Development Programme, first to demonstrate the method and then for commercial work. The International Irradiation Association counted about 40 gamma irradiators and about as many electron beam machines in India in 2025, and reports that Indian reactors made about 6.6 million curies of cobalt-60 available in 2023–24, enough for the whole domestic market.
Credit
India's Department of Atomic Energy; the United Nations Development Programme
2009
China makes its own cobalt
In 2004, by the IAEA's account, 90% of health care products made in China were sterilized with ethylene oxide gas, and 13 new cobalt-60 plants were being built. In January 2009 China National Nuclear Corporation began making cobalt-60 in the two Canadian-designed CANDU reactors of Qinshan Phase III, China's first domestic supply, planned at 6 million curies a year, about 80% of China's needs. Sotera Health's 2026 annual report confirms that Nordion buys part of its cobalt-60 from reactors in China.
Credit
China National Nuclear Corporation
2015
Two firms hold 85%
By evidence in a 2015 antitrust case, STERIS and Sterigenics together did about 85% of US contract sterilization and were the only two US contract gamma providers. The Federal Trade Commission tried to stop STERIS buying Synergy Health, arguing that Synergy would otherwise have brought X-ray sterilization to the US. A federal court in Ohio refused on 24 September 2015, and the FTC dropped the case on 30 October. Evidence in the case showed that no US customer had agreed to a long-term take-or-pay contract (a promise to pay for capacity whether used or not) for X-ray, and that one large device maker declined although it would have saved 50% of costs.
LessonA new kind of capacity waits for customers willing to retest their products and commit volume.
Credit
US Federal Trade Commission; US District Court for the Northern District of Ohio
2016
Planning for Pickering's end
In November 2016 Bruce Power and Ontario Power Generation (OPG), which with Nordion produced about 70% of the world's cobalt-60 in the Bruce B and Pickering CANDU reactors, agreed to expand production to the Darlington and Bruce A plants, because Pickering was due to close by 2024. Cobalt-60 takes up to three years in a reactor to make.
LessonThe world's gamma capacity rides on the schedules of a few power stations, which close and refurbish to suit the electricity grid, not sterilization.
Credit
Bruce Power; Ontario Power Generation
2019
A breathing tube runs short
After Illinois sealed Sterigenics' Willowbrook plant in February 2019 (see Medical devices), Smiths Medical and families reported a shortage of Bivona tracheostomy tubes, breathing tubes used by children, which had been sterilized there. The FDA helped move them to another Sterigenics plant, and shipments resumed the week of 22 April 2019. Later that year Sterigenics' Atlanta plant closed temporarily from 26 August to fit emission controls, Georgia's attorney general moved against BD's plant in Covington, and Viant told customers its Grand Rapids, Michigan, plant would close. For each, the FDA posted a list of the devices sterilized there, taken from its registration records.
LessonOutside the companies, no one knew which devices depended on which plant until a plant closed, and the links were traced one closure at a time.
Credit
US Food and Drug Administration; Smiths Medical
Watch for
Cobalt from Darlington
Nordion says OPG's refurbished Darlington Unit 1 has been producing cobalt-60 since January 2025 and Unit 4 since February 2026, with the first cobalt harvested after three years in the reactor, and that Darlington's four units could supply about 25% of current world demand.
Achieved whencobalt-60 harvested at Darlington is shipped to gamma plants, as confirmed by OPG, Canada's nuclear regulator or a buyer other than Nordion.
Claimed by
Nordion, with OPG, February 2026
Cobalt from US reactors
Westinghouse, Nordion and PSEG signed agreements to make cobalt-60 at PSEG's Salem 1 and 2 reactors in New Jersey, which they call the first production in pressurized water reactors, the most common type of power reactor. Nickel-plated cobalt-59 slugs are placed in inserts in the fuel assemblies, irradiated for three 18-month fuel cycles and removed in the plant's spent fuel pool. The US Nuclear Regulatory Commission (NRC) was reviewing PSEG's request to change its licence.
Achieved whenthe NRC approves the change and cobalt-60 from Salem is made into sources and delivered.
Claimed by
Westinghouse, Nordion and PSEG, January 2026
Open
01
One register of sterilizing plants
A public, downloadable table of every plant in the world that sterilizes medical devices for other companies, giving its owner, address, methods (gamma, electron beam, X-ray, ethylene oxide, other), a capacity measure for each method (millions of curies of cobalt-60 installed, accelerator power in kilowatts and energy in MeV, gas chamber volume), its opening and closing years, and the number of US device listings attached to it. Each row cites its source, so that when a plant closes, the devices at risk are known in advance.
The briefCredit · unclaimed02
A cobalt-60 ledger
A public, reactor-by-reactor model of the world's cobalt-60 for sterilization: which reactors make it (Bruce, Pickering, Darlington, Embalse and Atucha in Argentina, Leningrad in Russia, Qinshan in China, Indian reactors, Salem from about 2026), their outage and refurbishment dates from public records, the years each batch spends in the reactor, and decay of about 12% a year (a half-life of 5.3 years). Set against the cobalt installed in gamma plants, it would show the years when supply runs short, with scenarios such as Russian supply stopping.
The briefCredit · unclaimed
Open 01 · the brief
One register of sterilizing plants
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public, downloadable table of every plant in the world that sterilizes medical devices for other companies, giving its owner, address, methods (gamma, electron beam, X-ray, ethylene oxide, other), a capacity measure for each method (millions of curies of cobalt-60 installed, accelerator power in kilowatts and energy in MeV, gas chamber volume), its opening and closing years, and the number of US device listings attached to it. Each row cites its source, so that when a plant closes, the devices at risk are known in advance.
Why it is still open
The pieces sit apart. The IAEA's Database on Industrial Irradiation Facilities, updated in December 2020, maps "nearly 300" gamma irradiators and accelerators, cannot be downloaded, and leaves out ethylene oxide; a 2017 industry white paper alone counted more than 200 large gamma plants in about 50 countries. The FDA's openFDA registration data list 580 registrations in 50 countries that declare contract sterilization, with 32,949 device listings (counted through its API in November 2026), but give no method or capacity. Company filings give totals only: Sotera Health reports 48 sterilization facilities in 13 countries (23 gamma, 17 ethylene oxide, 8 electron beam), and STERIS more than 60. The FDA's 2019 closure lists show the device links could be drawn from registration records, but only after a plant had closed. The Medical devices file's Open item "Map single-plant devices" counts the plants that make each product in short supply; no table does the same for the plants that sterilize them.
Built with what exists
the openFDA device registration API; the IAEA facility map; US Nuclear Regulatory Commission and state licence records for irradiators; the EPA's list of ethylene oxide commercial sterilizers; company websites and annual reports; an AI model to read company pages and permits and quote the line behind each field, the kind of extraction job described in the Note "The jobs agents repeat"; a second person to check samples.
First step
Pull the 580 registrations from openFDA, find the methods for the first 50 on company websites, and compare them with the IAEA map.
Done looks like
All 580 openFDA registrations resolved to plants with methods and a source for each, plus every plant on the IAEA map matched or marked missing. A second person checks 100 random rows and agrees on at least 95%. For the four 2019 closures, the device counts in the register match the FDA's lists. The table is public and refreshed every three months.
Open 02 · the brief
A cobalt-60 ledger
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public, reactor-by-reactor model of the world's cobalt-60 for sterilization: which reactors make it (Bruce, Pickering, Darlington, Embalse and Atucha in Argentina, Leningrad in Russia, Qinshan in China, Indian reactors, Salem from about 2026), their outage and refurbishment dates from public records, the years each batch spends in the reactor, and decay of about 12% a year (a half-life of 5.3 years). Set against the cobalt installed in gamma plants, it would show the years when supply runs short, with scenarios such as Russian supply stopping.
Why it is still open
The public numbers disagree and come from sellers. A World Nuclear News report of 2016 says Bruce and Pickering made about 70% of world supply; Nordion and the American Nuclear Society said in 2026 that about 50% comes from Ontario. Sotera Health's 2026 annual report says about 20% of its long-term supply will come from Russian reactors, up to about 50% in some years, and that the Canadian licences for shipping targets to and from Russia expire in 2028. The National Academies' 2021 review of radioactive sources took its supply figures from a Nordion white paper, which put demand about 5% above supply. For molybdenum-99, a medical isotope, the OECD Nuclear Energy Agency publishes demand and capacity projections with supply scenarios, most recently for 2023 to 2027. Searches found nothing like it for cobalt-60, only paid market reports.
world-nuclear-news.organs.orgsec.govnationalacademies.orgoecd-nea.org
Built with what exists
refurbishment and outage schedules published by OPG and Bruce Power; the IAEA's Power Reactor Information System (PRIS) for reactor status; Canadian Nuclear Safety Commission licence records; company annual reports; a short Python model kept in a public repository.
First step
List each producing reactor with its published refurbishment dates and compute Ontario's share of production for 2026 to 2030.
Done looks like
The model, run on 2016 to 2025, reproduces the figures the producers disclosed in those years within 20%. A forecast to 2035 under three scenarios is published with every input linked to its source.